Governance Stichting LBSP

Board

Stichting LBSP is an independent not-for profit foundation, with 6 Founding Partners, representing 3 blood groups. Private parties, knowledge- and research institutions (public parties) as well as the (local) government are equally represented. Each of the Founding Partners has nominated a representative to be a Member of the Board.

No later than December 31st 2021 the Board will change Into a Supervisory Board. The Director will from than onwards also be the Board.

The current members of the Board are:

Members of the Board

Portrait of Bart van Zijll Langhout, PhD

Bart van Zijll Langhout, PhD

EMEA Vaccine Alliance Lead & Janssen The Netherlands Campus Lead On behalf of Janssen Biologics BV, chair of the Board
Portrait of Bas Reichert

Bas Reichert

CEO of BaseClear and chairman for the Entrepreneurial Association of the Leiden Bio Science Park On behalf of the Entrepreneurial Association of the Leiden Bio Science Park
Portrait of Hester Bijl, MD, PhD

Hester Bijl, MD, PhD

Rector magnificus van de Universiteit Leiden On behalf of the knowledge- and research institutes
Portrait of Pancras C.W. Hogendoorn, MD, PhD

Pancras C.W. Hogendoorn, MD, PhD

Dean and vice chair of the Board of the Leiden University Medical Center On behalf of the knowledge- and research institutes
Portrait of Paul Dirkse

Paul Dirkse

Alderman of the Municipality of Leiden On behalf of the public sector/municipalities
Portrait of H.J (Jan). T. Nieuwenhuis

H.J (Jan). T. Nieuwenhuis

Alderman of the Municipality of Oegstgeest On behalf of the public sector/municipalities

Advisory Council

The Advisory Council of the Stichting LBSP advices the Board/Supervisory Council and the Director about the vision and strategy of the Stichting LBSP. It gives Insights on relevant developments and trends In the (International) surroundings of the Stichting LBSP and how to take advantage of that. It provides ideas on the further transformation of the LBSP into a leading innovation district

Members participate on personal title and are asked because of their expertise and experience.

The setting up of the advisory council will be finalised In Q2 of 2021. The names of the members will soon after be published on this page.

Did you know? Our district is home to 71 drug development companies and services